Corneal Collagen Cross-Linking in Pellucid Marginal Degeneration: 2 Patients, 4 Eyes
Autor: | Şerife Bayraktar, Merih Oray, Nilufer Alparslan, Zafer Cebeci |
---|---|
Rok vydání: | 2014 |
Předmět: |
medicine.medical_specialty
Distance visual acuity Intrastromal corneal ring segment medicine.diagnostic_test genetic structures business.industry medicine.medical_treatment Pellucid marginal degeneration Corneal collagen cross-linking Case Report General Medicine medicine.disease Corneal topography eye diseases Left eye lcsh:Ophthalmology lcsh:RE1-994 Ophthalmology SPECULAR MICROSCOPY medicine Retrospective analysis sense organs business |
Zdroj: | Case Reports in Ophthalmological Medicine Case Reports in Ophthalmological Medicine, Vol 2015 (2015) |
ISSN: | 2090-6722 |
Popis: | Purpose. To report the long-term results of corneal collagen cross-linking (CXL) with riboflavin and ultraviolet-A irradiation in 4 eyes of 2 patients affected by pellucid marginal degeneration (PMD).Methods. This study involved the retrospective analysis of 4 eyes of 2 patients with PMD that underwent CXL treatment. Of the eyes, three had only CXL treatment and one had CXL treatment after an intrastromal corneal ring segment implantation. We have pre- and postoperatively evaluated uncorrected distance visual acuity (UDVA), best corrected distance visual acuity (BCDVA), corneal topography (Pentacam), specular microscopy, and pachymetry.Results. Patient 1 was a woman, aged 35, and Patient 2 was a man, aged 33. The right eye of Patient 1 showed an improvement in her BCDVA, from 16/40 to 18/20 in 15 months, and her left eye improved from 12/20 to 18/20 in 20 months. Patient 2’s right eye showed an improvement in his BCDVA, from 18/20 to 20/20 in 43 months, and his left eye improved from 16/20 to 18/20 in 22 months. No complications were recorded during or after the treatment.Conclusion. CXL is a safe tool for the management of PMD, and it can help to stop the progression of this disease. |
Databáze: | OpenAIRE |
Externí odkaz: |